Detalles de la búsqueda
1.
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Nephrology (Carlton)
; 22(7): 548-554, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27171136
2.
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
Am J Kidney Dis
; 65(1): 49-57, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115616
3.
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network.
Kidney Int
; 85(1): 23-30, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24088955
4.
Representativeness of Honeypot Trial Participants to Australasian PD Patients.
Perit Dial Int
; 37(5): 516-522, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27935534
5.
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.
Redox Rep
; 21(1): 14-23, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26083328
6.
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Perit Dial Int
; 35(7): 712-21, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26224790
7.
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Can J Kidney Health Dis
; 2: 33, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26284153
8.
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.
Lancet Infect Dis
; 14(1): 23-30, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24119840
Resultados
1 -
8
de 8
1
Próxima >
>>